• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射特考韦瑞玛治疗 HIV-1 患者口腔猴痘病变。

Intravenous tecovirimat treatment of oral monkeypox lesions in a patient with HIV-1.

机构信息

Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.

Division of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.

出版信息

J Med Virol. 2023 Sep;95(9):e29078. doi: 10.1002/jmv.29078.

DOI:10.1002/jmv.29078
PMID:37665172
Abstract

A man in his mid-30s presented with 1 week of painful, progressive, and confluent tongue and chin ulcerations. Swabs of the lesions were detected positive for monkeypox (mpox) DNA by polymerase chain reaction. During hospitalization, he received a diagnosis of human immunodeficiency virus-1. Due to severe oral pain, the patient was treated with intravenous tecovirimat 200 mg every 12 h for 4 days with remarkable improvement in lingual lesions. He completed a total 14-day course with oral tecovirimat. Our patient's clinical progress contributes to the data available for the potential efficacy of intravenous tecovirimat for mpox infection in humans.

摘要

一名 30 多岁的男性出现了 1 周的舌和下巴疼痛、进行性、融合性溃疡。病变拭子的聚合酶链反应检测到猴痘(mpox)DNA 呈阳性。住院期间,他被诊断为人免疫缺陷病毒-1。由于严重的口腔疼痛,患者接受了静脉注射替科韦马 200mg,每 12 小时一次,共 4 天,舌部病变明显改善。他完成了总共 14 天的口服替科韦马疗程。我们患者的临床进展为静脉注射替科韦马治疗人类猴痘感染的潜在疗效提供了可用数据。

相似文献

1
Intravenous tecovirimat treatment of oral monkeypox lesions in a patient with HIV-1.静脉注射特考韦瑞玛治疗 HIV-1 患者口腔猴痘病变。
J Med Virol. 2023 Sep;95(9):e29078. doi: 10.1002/jmv.29078.
2
A 40-Year-Old Man with Anemia, Proctitis, Rectal Bleeding, and a Perianal Rash Due to Mpox (Monkeypox) Infection.一位 40 岁男性,因感染猴痘(猴天花)出现贫血、直肠炎、直肠出血和肛周皮疹。
Am J Case Rep. 2023 Sep 3;24:e940177. doi: 10.12659/AJCR.940177.
3
Surveillance of Complicated Mpox Cases Unresponsive to Oral Tecovirimat in Los Angeles County, 2022.洛杉矶县 2022 年口服特考韦瑞玛特治疗无效的复杂猴痘病例监测。
J Infect Dis. 2024 Mar 26;229(Supplement_2):S249-S254. doi: 10.1093/infdis/jiad517.
4
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox.模拟目标试验中住院治疗的猴痘患者的疗效,评估特考韦瑞玛对愈合时间和病毒清除的影响。
J Med Virol. 2023 Jun;95(6):e28868. doi: 10.1002/jmv.28868.
5
Mpox in the New York metropolitan area, Summer 2022.2022年夏季纽约大都市地区的猴痘疫情
J Med Virol. 2023 Apr;95(4):e28699. doi: 10.1002/jmv.28699.
6
Severe soft tissue infection: A complication of mpox in an individual with HIV coinfection requiring vaccinia intravenous immunoglobulin and intravenous tecovirimat.严重软组织感染:HIV 合并感染个体中猴痘的并发症,需要接种牛痘静脉免疫球蛋白和替科韦瑞玛静脉注射。
J Med Virol. 2023 Jul;95(7):e28917. doi: 10.1002/jmv.28917.
7
Tecovirimat for the treatment of severe Mpox in Germany.特考韦瑞用于德国严重猴痘的治疗。
Infection. 2023 Oct;51(5):1563-1568. doi: 10.1007/s15010-023-02049-0. Epub 2023 Jun 5.
8
Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.天花病毒 Tecovirimat 静脉注射制剂的监管审批概述:对天花爆发应对能力的潜在影响,以及 Tecovirimat 的未来开发潜力。
Expert Rev Anti Infect Ther. 2023 Mar;21(3):235-242. doi: 10.1080/14787210.2023.2170350. Epub 2023 Feb 2.
9
Treatment with tecovirimat of the first two cases of monkeypox in Japan.日本前两例猴痘病例采用特考韦瑞治疗。
J Infect Chemother. 2023 Apr;29(4):418-421. doi: 10.1016/j.jiac.2023.01.011. Epub 2023 Jan 21.
10
Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak : A Retrospective Cohort Study.特考韦瑞玛治疗 2022 年猴痘疫情期间的 HIV 感染者:一项回顾性队列研究。
Ann Intern Med. 2023 May;176(5):642-648. doi: 10.7326/M22-3132. Epub 2023 May 2.